A multi-criteria support for the cost-effectiveness analysis of health interventions/ Uma contribuição multicritério para a análise de custo-efetividade de medicamentos
DOI:
https://doi.org/10.34119/bjhrv3n6-139Keywords:
Cost-effectiveness analysis, multi-criteria decision analysis, PROMÉTHÉE II method.Abstract
The use of multi-criteria decision analysis (MCDA) in the economic evaluation of drugs has been widely discussed. Thus, this study aims to propose a way to enhance the cost-effectiveness analysis (CEA) of health interventions using the PROMÉTHÉE II multi-criteria method. In order to accomplish this, PROMÉTHÉE II was applied to the same data used in the CEA of lipegfilgrastim in the Brazilian healthcare system for the reduction of chemotherapy-induced neutropenia. In this application, lipegfilgrastim and its comparators formed a set of alternatives. The cost parameters used to compute the total costs of the treatments along with the effectiveness outcomes formed a set of criteria, showing that a conventional CEA is in an MCDA setting. The CEA demonstrated lipegfilgrastim as a cost-saving strategy over its comparators. PROMÉTHÉE II generated the following outcomes to contribute to the CEA: (1) a ranking of studied interventions; (2) a classification level for each intervention from A (best level) to E (worst level); (3) a positioning scenario showing the dominance relation and distance among the interventions; and (4) a criteria panel classifying each criterion as strong or weak point for each intervention when compared to the others. The MCDA approach presented in this study does not exclude the use of CEA but complements it to support the decision-making process.
References
Edlin R, McCabe C, Hulme C, Hall P, Wright J. Cost effectiveness modelling for health technology assessment: a practical course. Heidelberg: Adis: Springer Cham; 2015.
Corbacho B, Drummond M, Santos R, et al. Does the use of health technology assessment have an impact on the utilisation of health care resources? Evidence from two European countries. Eur J Health Econ. 2020;21(4):621-34.
Briggs A, Sculpher M, Dawson J, Fitzpatrick R, Murray D, Malchau H. The use of probabilistic decision models in technology assessment. Appl Health Econ Health Policy. 2004;3(2):79-89.
O'Mahony JF, Newall AT, van Rosmalen J. Dealing with time in health economic evaluation: Methodological issues and recommendations for practice. Pharmacoeconomics. 2015;33(12):1255-68.
Schmidt M, Werbrouck A, Verhaeghe N, Putman K, Simoens S, Annemans L. Universal mental health interventions for children and adolescents: a systematic review of health economic evaluations. Appl Health Econ Health Policy. 2020;18(2):155-75.
Belton V, Stewart TJ. Multiple criteria decision analysis: an integrated approach. Massachusetts: Kluwer Academic Publishers; 2002.
Pomerol J-C, Barba-Romero S. Multicriterion decision in management: principles and practice. New York: Kluwer Academic Publisher; 2000.
Thokala P, Devlin N, Marsh K, Baltussen R, Boysen M, Kalo Z, Longrenn T, Mussen F, Peacock S, Watkins J, Ijzerman M. Multiple criteria decision analysis for health care decision making-an introduction: report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health. 2016;19(1):1-13.
Baltussen R, Niessen L. Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Eff Resour Alloc. 2006;4:14.
Goldman D, Walla DL, Philipson TJ, Yin W. Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA. Health Econ. 2010;19(10):1109-16.
Marsh KD, Sculpher M, Caro JJ, Tervonen T. The use of MCDA in HTA: great potential, but more effort needed. Value Health. 2018;21(4):394-7.
O'Mahony JF. Multi-criteria decision analysis from the cost-effectiveness perspectives: is a MCDA coherent way to allocate healthcare resources? Value Health. 2016;19(7):A397-8.
Angelis A, Kanavos P. Multiple criteria decision analysis (MCDA) for evaluating new medicines in health technology assessment and beyond: the advance value framework. Soc Sci Med. 2017;188:137-56.
Postmus D, Tervonen T, van Valkenhoef G, Hillege HL, Buskens L. A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions. Eur J Health Econ. 2014;15(7):709-16.
Campillo-Artero C, Puig-Junoy J, Culyer AJ. Does MCDA trump CEA? Appl Health Econ Health Policy. 2018;16(2):147-51.
Goetghebeur MM, Wagner M, Khoury H, Levitt RJ, Erickson LJ, Rindress D. Evidence and value: impact on decision making-the EVIDEM framework and potential applications. BMC Health Serv Res. 2008;8:270.
Garattini L, Padula A. Multiple criteria decision analysis in health technology assessment for drugs: just another illusion? Appl Health Econ Health Policy. 2018;16(1):1-4.
Castro JP, Mosegui GBG, Costa TMA da. Application of multiple criteria decision analysis (MCDA) for the selection of pharmacological treatments. Brazilian J Heal Rev. 2020;3(5):13154–69.
Sallum FSV, Marasco GL, Asano E, Fahham L, Amaral LM, Pepe C. PRO41 A multi-criteria decision analysis contribution to the Canadian intravenous immunoglobulin cost-effectiveness analysis. Value Health. 2020;23:S336.
Szende A, Urwongse J, Szabo E, Klastersky J, Mueller UW, Stefani SD, Tang B. Cost-effectiveness and budgetary impact of lipegfilgrastim for the reduction of chemotherapy-induced neutropenia in Brazil. J Bras Econ Saúde. 2018;10(2):107-17.
Roy B, Bouyssou D. Aide multicritère à la décision: méthodes et cas. Paris: Econômica; 1993.
Vincke, PH. L'aide multicritère à la dècision. Bruxelles: Éditions de l'Université de Bruxelles; 1989.
Saaty TL. The analytic hierarchy process. New York: McGraw Hill; 1980.
Saaty TL. Fundamentals of decision making and priority theory: with the analytic hierarchy process. Pittsburgh: RWS Publications; 1994.
Keeney RL, Raiffa H. Decisions with multiple objectives: preferences and value tradeoffs. Cambridge: Cambridge University Press; 1993.
Hwang CL, Yoon K. Multiple attribute decision making: methods and applications. Berlin: Springer-Verlag; 1981.
Behzadian M, Otaghsara SK, Yazdani M, Ignatius J. A state-of the-art survey of TOPSIS applications. Expert Syst Appl. 2012;39(17):13051-69.
Gomes LFAM, Lima MMPP. TODIM: basics and application to multi-criteria ranking of projects with environmental impacts. Found Comput Decis Sci. 1991;16(3-4):113-27.
Gomes LFAM, Rangel LAD. An application of the TODIM method to multi-criteria rental evaluation of residential properties. Eur J Oper Res. 2009;193(1):204-11.
Mühlbacher AC, Kaczynski A. Making good decisions in Healthcare with multi-criteria decision analysis: the use, current research and future development of MCDA. Appl Health Econ Health Policy. 2016;14(1):29-40.
Velasquez M, Hester PT. An analysis of multi-criteria decision making methods. Int J Oper Res. 2013;10(2):56-66.
Turner AJ, Sutton M, Harrison M, Hennessey A, Humphrey N. Cost-effectiveness of a school-based social and emotional learning intervention: evidence from a cluster-randomised controlled trial of the promoting alternative thinking strategies curriculum. Appl Health Econ Health Policy. 2020;18(2):271-85
Amaral TM, Costa APC. Improving decision-making and management of hospital resources: an application of the PROMETHEE II method in an emergency department. Oper Res Health Care. 2014;3(1):1-6.
Sallum FSV, Gomes LFAM, Machado MAS. The TODIM multi-criteria method applied to the ANBIMA ranking of Brazilian investment funds. Int J Bus Syst Res. 2020;14(1):56-73.
Roy B. The outranking approach and the foundations of ELECTRE methods. Theory Decis. 1991;31(1):49-73.
Hummel JM, Steuten LGM, Groothuis-Oudshoorn CJM, Mulder N, IJzerman. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis. Appl Health Econ Health Policy. 2013;11(5):499-507.
Improta G, Converso G, Murino T, Gallo M, Perrone A, Romano M. Analytic hierarchy process (AHP) in dynamic configuration as a tool for health technology assessment (HTA): the case of biosensing optoelectronics in oncology. Int J Inf Tech Decis. 2019;18(5):1533-50.
Bana e Costa CA, Corte JM, Vasnick JC. MACBETH. Int J Inf Tech Decis. 2012;11(2):359-87.
Chalgham M, Khatrouch I, Masmoudi M, Walha OC, Dammak A. Inpatient admission management using multiple criteria decision-making methods. Oper Res Health Care. 2019;23:100173.
Marsh K, Caro JJ, Hamed A, Zaiser E. Amplifying each patient's voice: a systematic review of multi-criteria decision analyses involving patients. Appl Health Econ Health Policy. 2016;15(2):155-62.
Marsh K, Lanitis T, Neasham D, Orfanos P, Caro J. Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature. Pharmacoeconomics. 2014;24(4):345-65.
Ghabri S, Josselin J-M, Maux BL. Could or should we use MCDA in the French HTA process? Pharmacoeconomics. 2019;37(12):1417-19.
Brans JP, Vincke P, Mareschal B. How to select and how to rank projects: the PROMETHEE method. Eur J Oper Res. 1986;24(2):228-38.
Brans JP, Vincke P. A preference ranking organisation method: the PROMETHEE method for multiple criteria decision-making. Manage Sci. 1985;31(6):647-56.
Mladineo M, Jajac N, Rogulj K. A simplified approach to the PROMETHEE method for priority setting in management of mine action projects. Croat Oper Res Rev. 2016;7:249-68.
Podvezko V, Podviezko A. Dependence of multi-criteria evaluation result on choice of preference functions and their parameters. Technol Econ Dev Econ. 2010;16(1):143-58.
Sallum FSV, Aguiar EW, Lins L, Pontes A, Amaral LM, Fernandes RA. PMU12 A non-communicable diseases multi-criteria analysis in Latin America. Value Health Reg Issues. 2019;19:S57-8.
Sallum FSV, Amaral LM, Fernandes RA. PMU13 A multi-criteria approach to the study of chronic non-communicable diseases in Brazil. Value Health Reg Issues. 2019;19:S58.
